Skip to main content
. 2021 Jun 23;43(4):1643–1652. doi: 10.1007/s11357-021-00399-x

Table 1.

Characteristics at baseline of the included patients and lost to follow-up patients

Demographics and risk factors Included in follow-up n = 51 Lost to follow-up n = 29 P-value
Age, years (SD) 67 (12) 75.1 (7) 0.001*
Male (%) 30 (59) 16 (55) 0.755
Lacunar stroke/mVCI (%) 36 (71)/ 15 (29) 8 (28)/21 (73)  < 0.001*
Educational level (%) 0.385
  Low 24 (47) 11 (38)
  Average 18 (35) 11 (38)
  High 9 (18) 7 (24)
Hypertension (%) 33 (65) 18 (62) 0.816
Hypercholesterolemia (%) 29 (60) 16 (55) 0.885
Diabetes (%) 4 (8) 8 (28) 0.017*
BMI kg/m2 (SD) 26 (4) 25 (4) 0.493
Coronary artery disease (%) 6 (12) 9 (31) 0.034*
Peripheral artery disease (%) 2 (4) 3 (10) 0.259
Smoking (%) 14 (28) 5 (17) 0.308
Time to follow-up, months (SD) 26 (1) -
MRI measures
  Relative brain volume (SE) 0.675 (0.007) 0.654 (0.008) 0.633
  Relative WMH volume (SE) 0.014 (0.002) 0.016 (0.003) 0.058
  Total WMH Fazekas score, median (IQR) 4 (2–6) 4 (3–6) 0.197
  Silent lacunar infarct (%) 26 (51) 12 (41) 0.588
  Microbleeds (%) 12 (24) 6 (21) 0.898
BBB leakage volume: vL (%)
  NAWM (SD) 32 (16) 41 (16) 0.030*
  WMH (SD) 39 (19) 48 (20) 0.067
  CGM (SD) 18 (11) 24 (13) 0.035*
  DGM (SD) 30 (19) 40 (17) 0.030*
BBB leakage rate: Ki (10−4 min−1)
  NAWM (SD) 3.1 (1.6) 3.6 (1.4) 0.195
  WMH (SD) 3.4 (2.0) 3.9 (1.9) 0.280
  CGM (SD) 2.3 (1.2) 2.4 (1.1) 0.069
  DGM (SD) 3.1 (2.0) 3.7 (2.0) 0.155

SD, standard deviation; SE, standard error; IQR, interquartile range; BMI, body mass index; NAWM, normal-appearing white matter; WMH, white matter hyperintensities; CGM, cortical grey matter; DGM, deep cortical grey matter; Brain volume, brain volume normalized to intracranial volume; WMH volume, WMH volume normalized to intracranial volume. Total Fazekas score: Periventricular (0–3) and deep (0–3) WMH scores were summed. * P < 0.05